Chronic Polyradiculoneuritis Latest Advances

Find the Latest Research About Chronic Polyradiculoneuritis

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2040 publications

Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.

Matching-adjusted indirect treatment comparisons in chronic inflammatory demyelinating polyneuropathy: interpreting current evidence and enhancing future studies.

Journal: Journal of comparative effectiveness research

Published: October 09, 2026

Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Journal: Continuum (Minneapolis, Minn.)

Published: October 02, 2026

Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy.

Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy.

Journal: Journal of medical economics

Published: September 21, 2026

Chronic Complications Following Dengue Infection: A Scoping Review.

Chronic Complications Following Dengue Infection: A Scoping Review.

Journal: Cureus

Published: September 21, 2026

Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy.

Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy.

Journal: Internal medicine (Tokyo, Japan)

Published: September 16, 2026

Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: An Atypical Chronic Inflammatory Demyelinating Polyradiculoneuropathy Variant Responsive to Intravenous Immunoglobulin.

Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: An Atypical Chronic Inflammatory Demyelinating Polyradiculoneuropathy Variant Responsive to Intravenous Immunoglobulin.

Journal: Cureus

Published: September 07, 2026

Chronic Inflammatory Demyelinating Polyneuropathy: Update on Diagnosis and Treatment.

Chronic Inflammatory Demyelinating Polyneuropathy: Update on Diagnosis and Treatment.

Journal: Journal of clinical neuromuscular disease

Published: September 02, 2026

Clinical heterogeneity in chronic inflammatory demyelinating polyneuropathy: data-driven subtypes challenge current classification.

Clinical heterogeneity in chronic inflammatory demyelinating polyneuropathy: data-driven subtypes challenge current classification.

Journal: Journal of neurology

Published: August 31, 2026

When Guillain-Barré syndrome is not monophasic: Distinguishing recurrent Guillain-Barré syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies

When Guillain-Barré syndrome is not monophasic: Distinguishing recurrent Guillain-Barré syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies

Journal: Medicina

Published: August 27, 2026

Clinical practice and research of chronic inflammatory demyelinating polyneuropathy: current status and future

Clinical practice and research of chronic inflammatory demyelinating polyneuropathy: current status and future

Journal: Rinsho shinkeigaku = Clinical neurology

Published: August 26, 2026

Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barré Syndrome of a Severe Refractory Case.

Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy May Manifest as Recurrent Guillain-Barré Syndrome of a Severe Refractory Case.

Journal: Internal medicine (Tokyo, Japan)

Published: August 19, 2026

Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial.

Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial.

Journal: Internal medicine (Tokyo, Japan)

Published: August 19, 2026

Showing 1-12 of 2,040

Last Updated: 11/08/2026